Validation of the LiverFASt Test and the Associated Fibrosis Staging Scores Compared to Liver Tissue Pathology Via Liver Biopsy

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

September 1, 2019

Primary Completion Date

September 1, 2020

Study Completion Date

November 1, 2020

Conditions
NAFLDNASH
Interventions
DIAGNOSTIC_TEST

LiverFASt

LiverFASt™ is a blood based diagnostic test utilizing a patented algorithm to determine presence and the progression of liver disease. The test is non-invasive, simple, and less expensive than liver biopsy or liver imaging.

Trial Locations (1)

32817

ObvioHealth, Orlando

Sponsors
All Listed Sponsors
collaborator

OBVIO HEALTH USA, Inc.

UNKNOWN

lead

Fibronostics USA, Inc

OTHER